Pages that link to "Q52918729"
Jump to navigation
Jump to search
The following pages link to Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. (Q52918729):
Displaying 50 items.
- Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) (Q22061981) (← links)
- Tricyclic antidepressants for ADHD in children and adolescents (Q24243688) (← links)
- Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis (Q26824097) (← links)
- Stimulant drugs (Q28141748) (← links)
- Safety of stimulant treatment in attention deficit hyperactivity disorder: part II. (Q30451303) (← links)
- What is attention-deficit hyperactivity disorder (ADHD)? (Q33231807) (← links)
- Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia (Q33718175) (← links)
- Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder (Q33799533) (← links)
- Attention deficit hyperactivity disorder--a review (Q33809083) (← links)
- Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies (Q33819024) (← links)
- Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial (Q33988480) (← links)
- The stimulants revisited. (Q34005063) (← links)
- Non-stimulant treatments for ADHD. (Q34120068) (← links)
- Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study (Q34196989) (← links)
- Omega-3 fatty acids in ADHD and related neurodevelopmental disorders (Q34538615) (← links)
- Child anxiety disorders in public systems of care: comorbidity and service utilization (Q34679561) (← links)
- Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management (Q35568743) (← links)
- Non-stimulant medications in the treatment of ADHD. (Q35868196) (← links)
- Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders (Q36057319) (← links)
- The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder (Q36082025) (← links)
- Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test. (Q37196979) (← links)
- Psychiatric comorbidity in Korean children and adolescents with attention-deficit hyperactivity disorder: psychopathology according to subtype (Q37205095) (← links)
- A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment (Q37235736) (← links)
- Effects of methylphenidate in children with attention deficit hyperactivity disorder: a comparison of event-related potentials between medication responders and non-responders (Q38456059) (← links)
- Predictors of Response to Behavioral Treatments Among Children With ADHD-Inattentive Type (Q39223712) (← links)
- Comorbidity in ADHD: Implications for Research, Practice, and DSM-V (Q40886212) (← links)
- Comorbidity and Factors Affecting Treatment Non-Persistence in ADHD. (Q40905411) (← links)
- Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder? (Q42145069) (← links)
- Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment (Q43235419) (← links)
- Family correlates of comorbid anxiety disorders in children with attention deficit/hyperactivity disorder (Q43718879) (← links)
- Association between ADHD symptoms and anxiety symptoms in Taiwanese adolescents (Q44960045) (← links)
- Physical Activity, Affect, and Cognition in Children With Symptoms of ADHD. (Q44998777) (← links)
- Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. (Q46132567) (← links)
- Latent Class Analysis of ADHD Neurodevelopmental and Mental Health Comorbidities (Q47271323) (← links)
- A Review of the Clinical Utility of Systematic Behavioral Observations in Attention Deficit Hyperactivity Disorder (ADHD). (Q47566848) (← links)
- The effect of methylphenidate treatment on suspiciousness in children with ADHD alone or comorbid with ODD. (Q47610610) (← links)
- Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration (Q48409200) (← links)
- Anxiety and methylphenidate in attention deficit hyperactivity disorder: a double-blind placebo-drug trial (Q50578431) (← links)
- Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis (Q50659644) (← links)
- Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder (Q50891899) (← links)
- A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities (Q51015689) (← links)
- Differential Effects of Methylphenidate on Working Memory in ADHD Children with and without Comorbid Anxiety (Q52052538) (← links)
- The use of psychostimulants in the pediatric patient. (Q52180613) (← links)
- Predicting methylphenidate response in attention deficit hyperactivity disorder: A preliminary study (Q57435671) (← links)
- History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder (Q60491954) (← links)
- Treatment of attention deficit hyperactivity disorder in children (Q60630249) (← links)
- Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol (Q61359528) (← links)
- Is there a comorbid relationship between hyperactivity and emotional psychopathology? (Q73909742) (← links)
- Managing ADHD in children, adolescents, and adults with comorbid anxiety in primary care (Q80558994) (← links)
- Pharmacological treatment in adults with attention deficit hyperactivity disorder (Q81020354) (← links)